Breadcrumb
Equipo ISGlobal - Título

Equipo ISGlobal

PeopleCategories
People
Raquel González

Raquel González

Associated Researcher Salud materna, infantil y reproductiva | Infecciones víricas y bacterianas en el mundo

Dr. Raquel González is a medical epidemiologist working as Senior Ramón y Cajal Researcher at the University of Barcelona, ISGlobal and the Centro de Investigaçao em Saúde de Manhiça (CISM) in Mozambique.

She earned a medical degree and a doctoral degree in Medicine from the Universitat de Barcelona and a Master in Public Health from the Universitat Pompeu Fabra. She is also Specialist in Preventive Medicine and Public Health (Hospital Clínic medial residency) and obtained the HDR diploma from the Université de Paris.

For the past 20 years she has worked as coordinator, project manager and investigator of several clinical and epidemiological studies in Morocco, Mozambique and Kenya, focusing on poverty-related diseases such as malaria, HIV and Maternal and child health.  She has experience in the evaluation of vaccine and drugs, including design, clinical trials and analysis of large implementation science projects.

Since 2012, she collaborates with the Global Malaria Program at WHO providing technical inputs and updating the guidelines for prevention of malaria in pregnancy.

She is co- coordinator of the Maternal and Reproductive Health course and lecturer at the Master of Global Health from the University of Barcelona (Spain).

Líneas de investigación

  • Maternal and Child Health
  • Malaria
  • HIV
  • Infectious Diseases
  • Vaccine and Drug development
  • Implementation Science

Principales publicaciones

  • González R, Nhampossa T, Mombo-Ngoma G, et al. Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial. The Lancet Infectious diseases. 2024;24(5):476-487.
  • González R, Manun'Ebo MF, Meremikwu M, et al. The impact of community delivery of intermittent preventive treatment of malaria in pregnancy on its coverage in four sub-Saharan African countries (Democratic Republic of the Congo, Madagascar, Mozambique, and Nigeria): a quasi-experimental multicentre evaluation. The Lancet Global health. 2023;11(4):e566-e574.
  • Figueroa-Romero A, Saura-Lázaro A, Fernández-Luis S, González R. Uncovering HIV and malaria interactions: the latest evidence and knowledge gaps. The lancet HIV. 2024;11(4):e255-e267.
  • Gonzalez R, Augusto OJ, Munguambe K, et al. HIV Incidence and Spatial Clustering in a Rural Area of Southern Mozambique. PloS one. 2015;10(7):e0132053.
  • Gonzalez R, Desai M, Macete E, et al. Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Infected Women Receiving Cotrimoxazole Prophylaxis: A Multicenter Randomized Placebo-Controlled Trial. PLoS Med. 2014;11(9):e1001735.
Publicador de contenidos